Sensorion Ends Patient Inclusion in NOTOXIS Phase 2a Trial
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today...